USD 56.88
(-1.51%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 | 195.46 Million USD | 45.54% |
2023 | 125.1 Million USD | 14.18% |
2022 | 113.53 Million USD | 108.01% |
2021 | 63.9 Million USD | 147.17% |
2020 | 26.41 Million USD | 208.66% |
2019 | 7.47 Million USD | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 FY | - USD | 34.48% |
2024 Q4 | 44.4 Million USD | -27.28% |
2024 Q2 | 52.26 Million USD | 49.35% |
2024 Q3 | 61.32 Million USD | 37.73% |
2024 Q1 | 32.28 Million USD | -25.72% |
2023 Q3 | 41.1 Million USD | 18.48% |
2023 FY | - USD | 14.18% |
2023 Q4 | 35.54 Million USD | -13.51% |
2023 Q2 | 34.69 Million USD | 44.23% |
2023 Q1 | 24.05 Million USD | -17.88% |
2022 Q3 | 37.15 Million USD | 42.29% |
2022 Q4 | 29.28 Million USD | -21.16% |
2022 Q1 | 26.02 Million USD | 9.19% |
2022 FY | - USD | 108.01% |
2022 Q2 | 26.1 Million USD | 0.31% |
2021 Q4 | 23.83 Million USD | 25.79% |
2021 FY | - USD | 147.17% |
2021 Q1 | 2.85 Million USD | -74.91% |
2021 Q3 | 18.95 Million USD | 66.75% |
2021 Q2 | 11.36 Million USD | 298.63% |
2020 Q3 | 7.61 Million USD | 0.0% |
2020 Q4 | 11.36 Million USD | 49.19% |
2020 FY | - USD | 208.66% |
2019 FY | - USD | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
American Well Corporation | -225.99 Million USD | 186.493% |
Evolent Health, Inc. | -24.78 Million USD | 888.65% |
MultiPlan Corporation | 651.93 Million USD | 70.017% |
Phreesia, Inc. | -102.94 Million USD | 289.875% |
Teladoc Health, Inc. | 153.99 Million USD | -26.929% |
Veeva Systems Inc. | 429.33 Million USD | 54.472% |